New Delhi, Oct. 10 -- The government of India has decided to cap trade margins on non-scheduled anti-cancer drugs at 30 %, according to the Indian Pharmaceutical Alliance (IPA). The announcement of trade margin rationalisation for cancer medicines is a welcome step.

As per the Indian Pharmaceutical Alliance (IPA), the announcement of trade margin rationalisation for cancer medicines is a welcome step. Medicine prices in India are among the lowest in the world. Indian companies play a vital role in providing quality-assured, affordable medicines. This is a balanced approach for patient welfare while assuring adequate margins to the channel members.

On the other hand, top medical experts have suggested ensuring actual patient savings with...